Lubricious coating for medical device
Embodiments of the disclosure include lubricious coatings. In an embodiment the disclosure includes a lubricious coating for a medical device including an acrylic acid polymer, an acrylamide copolymer comprising at least one photoreactive group, and a cross-linking agent comprising at least two photoreactive groups. The coating can be used on a catheter surface to facilitate its movement in the body.
1 . A medical device comprising a lubricious coating disposed on and in direct contact with a substrate of the medical device, wherein the lubricous coating is formed from a liquid coating composition comprising:
a first polymer that is an acrylic acid polymer, a second polymer that is an acrylamide copolymer comprising at least one photoreactive group, and a cross-linking agent comprising at least two photoreactive groups, wherein the liquid coating composition has a pH of less than about 6,
wherein the substrate consists of one or more selected from the group consisting of metal, ceramic, glass and polymer, and
wherein the polymer is one or more selected from the group consisting of polyurethanes, polyolefins, polyethylene, styrene-butadiene copolymers, polyisoprene, isobutylene-isoprene copolymers, butyl rubber, halogenated butyl rubber, butadiene-styrene-acrylonitrile copolymers, silicone polymers, fluorosilicone polymers, polycarbonates, polyamides, polyesters, polyvinyl chloride, polyether-polyester copolymers, polyether-polyamide copolymers, acrylic polymers and copolymers, vinyl polymers and copolymers, polysulfones, polydimethylsiloxanes, polyetherketones, and polyimides.
2 . The medical device of claim 1 comprising a catheter, wherein the catheter is configured to be inserted into a subject transitorily.
3 . The medical device of claim 1 , wherein the liquid coating composition has a pH in the range of pH 3-5.
4 . The medical device of claim 1 , wherein the liquid coating composition has a pH in the range of pH 2-6.
5 . The medical device of claim 1 , wherein the liquid coating composition comprises water and an alcohol, wherein the alcohol is present in an amount in the range of 5-45% (v/v) in the liquid coating composition.
6 . The medical device of claim 1 , wherein the acrylic acid polymer of the liquid coating composition is an acrylic acid homopolymer.
7 . The medical device of claim 1 , wherein the second polymer of the liquid coating composition comprises acrylamide-2-acrylamido-2-methylpropanesulfonate (AMPS)-and poly (ethylene glycol)-containing subunits.
8 . The medical device of claim 1 , wherein the first polymer of the liquid coating composition is present in an amount in the range of 20 to 80% (wt) and the second polymer is present in an amount in the range of 10 to 60% (wt) of solids components in the liquid coating composition, and the first and second polymers constitute about 90% (wt) or greater of the polymeric materials of the coating composition.
9 . The medical device of claim 8 , wherein the first polymer is present in an amount in the range of 30 to 70% (wt) and the second polymer is present in an amount in the range of 10 to 60% (wt) of solids components in the liquid coating composition, and the first and second polymers constitute about 98% (wt) or greater.
10 . The medical device of claim 8 , wherein the first and second polymers constitute about 95% (wt) or greater of the polymeric materials of the coating composition.
11 . The medical device of claim 1 , wherein the cross-linking agent of the liquid coating composition is a compound of a formula selected from:
wherein R 1 , R 2 , R 8 and R 9 are any substitution; R 3 , R 4 , R 6 and R 7 are alkyl, aryl, or a combination thereof; R 5 is any substitution; and each X, independently, is O, N, Se, S, or alkyl, or a combination thereof;
wherein R 1 and R 5 are any substitution; R 2 and R 4 can be any substitution, except OH; R 3 can be alkyl, aryl, or a combination thereof; and each X, independently, is O, N, Se, S, alkyl or a combination thereof;
wherein R 1 , R 2 , R 4 and R 5 are any substitution; R 3 is any substitution; R 6 and R 7 are alkyl, aryl, or a combination thereof; and each X, independently, is O, N, Se, S, alkyl, or a combination thereof; and
12 . The medical device of claim 1 , wherein the lubricous coating is formed from the liquid coating composition as a single coated layer having a thickness in the range of about 100 nm to about 5.0 μm.
13 . The medical device of claim 1 wherein the lubricious coating releases less than 3,000 particles having a size greater than 10 microns per 600 mm2 of lubricious coating, under the test conditions of ASTM F2394.
14 . The medical device of claim 1 wherein the lubricious coating has a lubricity that is greater than a coating composition prepared with identical materials but having a pH greater than 6.0.
15 . The medical device of claim 1 wherein the lubricious coating releases a number of particle that is less than the number of particles released from a coating composition prepared with identical materials but having a pH greater than 6.0, wherein the particles released have a size greater than 10 microns, and the number of particles released is measured under the test conditions of ASTM F2394.
16 . A method for treating a subject comprising inserting the medical device comprising the lubricious coating of claim 1 into the subject.
17 . A medical device comprising a lubricious coating disposed on and in direct contact with a substrate of the medical device, wherein the lubricous coating is formed from a liquid coating composition comprising:
a first polymer that is an acrylic acid polymer, a second polymer that is an acrylamide copolymer comprising at least one photoreactive group, and a cross-linking agent comprising at least two photoreactive groups, wherein the liquid coating composition has a pH of less than about 6, and
wherein the medical device does not include a primer layer between the substrate and the lubricious coating.
18 . The medical device of claim 17 comprising a catheter, wherein the catheter is configured to be inserted into a subject transitorily.
19 . The medical device of claim 17 , wherein the acrylic acid polymer of the liquid coating composition is an acrylic acid homopolymer, and the second polymer of the liquid coating composition comprises acrylamide-2-acrylamido-2-methylpropanesulfonate (AMPS)-and poly (ethylene glycol)-containing subunits.
20 . The medical device of claim 17 , wherein the liquid coating composition has a pH in the range of about 3 to about 5.